image credit: Freepik

Rapid AI adoption in the field of cardiology

May 18, 2023


Medical device companies have had to rapidly adopt emerging technologies such as artificial intelligence (AI) to accommodate the lack of in-person visitations during the Covid-19 pandemic. GlobalData forecasts that medical device companies’ spending on AI is set to witness a compound annual growth rate of 20.6% between 2019 and 2024, and this trend is expected to continue in the future.

Recently, the FDA published a list of artificial AI-enabled medical devices that were approved by the FDA in 2022. Approximately 57% of these devices fall under cardiology. One area of cardiology where researchers are trying to incorporate AI is in predicting heart attacks before they happen.

Read More on Medical Device Network